Cost effectiveness of selective decontamination of the digestive tract in liver transplant patients

PharmacoEconomics

Volumn 19, Issue 5, 2001, Pages 523-530

  van Enckevort, Petra J ^a   Zwaveling, Jan H ^a   Bottema, Jan T ^a   Maring, John K ^a   Klompmaker, Ids J ^a   Slooff, Maarten J H ^a   TenVergert, Elisabeth M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIINFECTIVE AGENT; COLISTIN; HYDROXYPROPYLMETHYLCELLULOSE; NORFLOXACIN; PLACEBO; TOBRAMYCIN SULFATE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISINFECTION; DOUBLE BLIND PROCEDURE; FEMALE; GASTROINTESTINAL INFECTION; GASTROINTESTINAL TRACT; HEALTH CARE COST; HUMAN; INFECTION PREVENTION; INTESTINE FLORA; LIVER TRANSPLANTATION; LOZENGE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PREOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTI-BACTERIAL AGENTS; COST-BENEFIT ANALYSIS; DIGESTIVE SYSTEM; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LENGTH OF STAY; LIVER TRANSPLANTATION; MALE; NETHERLANDS; POSTOPERATIVE COMPLICATIONS; SURGICAL WOUND INFECTION;

EID: 0035009611     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200119050-00007     Document Type: Article

References (28)

1. Wade JJ, Rolando N, Hayllar K, et al. Bacterial and fungal infections after liver transplantation: an analysis of 284 patients. Hepatology 1995; 21: 1328-36
2. Stoutenbeek CP, van Saene HKF, Miranda DR, et al. The effect of selective decontamination of the digestive tract on colonization and infection rate in multiple trauma patients. Int Care Med 1984; 10: 185-92
3. Hammond JM, Potgieter PD, Saunders GL, et al. Double-blind study of selective decontamination of the digestive tract in intensive care. Lancet 1992; 340: 5-9
4. Gastinne H, Wolff M, Delatour F, et al. A controlled trial in intensive care units of selective decontamination of the digestive tract with nonabsorbable antibiotics. N Engl J Med 1992; 326: 594-9
5. Verwaest C, Verhaegen J, Ferdinande P, et al. Randomized, controlled trial of selective digestive decontamination in 600 mechanically ventilated patients in a multidisciplinary intensive care unit. Crit Care Med 1997; 25: 63-71
6. Vandenbroucke-Grauls CMJE, Vandenbroucke JP. Effect of selective decontamination of the digestive tract on respiratory tract infections and mortality in the intensive care unit. Lancet 1991; 338: 859-62
7. SDD Triallists' Collaborative Group. Meta-analysis of randomised controlled trials of selective decontamination of the digestive tract. BMJ 1993; 307: 525-32
8. Heyland DK, Cook DJ, Jaescher R, et al. Selective decontamination of the digestive tract. An overview. Chest 1994; 105: 122-9
9. Kollef M. The role of selective digestive tract decontamination on mortality and respiratory tract infections: a meta-analysis. Chest 1994; 105: 1221-9
10. D'Amico R, Pifferi S, Leonetti C, et al. Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials. BMJ 1998; 316: 1275-85
11. Nardi G, Valentinis U, Proietti A, et al. Epidemiologic impact of prolonged systematic use of topical SDD on bacterial colonization of the tracheobronchial tree and antibiotic resistance. Int Care Med 1993; 19: 273-8
12. Kaufhold A, Behrendt W, Kräuss T, et al. Selective decontamination of the digestive tract and methicillin-resistant Staphylococcus aureus. Lancet 1992; 339: 1411-2
13. Nau R, Ruchel R, Mergerian H, et al. Emergence of antibiotic-resistant bacteria during selective decontamination of the digestive tract. J Antimicrob Chemother 1990; 25: 881-3
14. Rocha LA, Martin MJ, Pita S, et al. Prevention of nosocomial infection in critically ill patients by selective decontamination of the digestive tract: a randomized, double blind, placebo-controlled study. Intensive Care Med 1992; 18: 398-404
15. Korinek AM. Laisne MJ, Nicolas MH, et al. Selective decontamination of the digestive tract in neurosurgical intensive care unit patients: a double-blind, randomized, placebo-controlled study. Crit Care Med 1993; 21 (10): 1466-73
16. Langlois-Karaga A, Bues-Charbit M, Davignon A. et al. Selective digestive decontamination in multiple trauma patients: cost and efficacy. Pharm World Sci 1995; 17 (1): 12-6
17. Quinio B, Albanese J, Bues-Charbit M, et al. Selective decontamination of the digestive tract in multiple trauma patients: a prospective double-blind, randomized, placebo-controlled study [comment]. Chest 1996; 110(6): 1625-6
18. Stoutenbeek CP, Saene HKF van, Zandstra DF. Prevention of multiple organ system failure by selective decontamination of the digestive tract in multiple trauma patients. In: Faist E, Baue AE, Schildberg FW, editors. The immune consequences of trauma, shock and sepsis. Lengerich: Pabst Sciences Publishers, 1996: 1055-66
19. Sanches-Garcia M, Cambronero-Galache JA. Lopez-Diaz J, et al. Effectiveness and cost of selective decontamination of the digestive tract in critically ill intubated patients: a randomized, double-blind, placebo-controlled, multicenter trial. Am J Respir Crit Care Med 1998: 158 (3): 908-16
20. Drummond MF, O'Brien B, Stoddart GL, et al. Methods for the economic evaluation of health care programmes. 2nd ed. Oxford: Oxford University Press, 1997
21. Thompson SG, Barber JA. How should cost data in pragmatic randomised trials be analysed? BMJ 2000; 320: 1197-200
22. Buxton MR, Acheson R, Caine N, et al. Costs and benefits of the heart transplantation programmes at Harefield and Papworth Hospitals. London: HMSO, 1985
23. Bonsel GJ, Klompmaker IJ, Essink-Bot ML, et al. Cost-effectiveness analysis of the Dutch liver transplantation programme. Transplant Proc 1990; 22: 1481-4
24. Hout van BA, Bonsel G, Habbema D, et al. Heart transplantation in the Netherlands; costs, effects and scenarios. J Health Econ 1993; 12: 73-93
25. Enckevort PJ van, Koopmanschap MA, TenVergert EM, et al. Lifetime costs of lung transplantation; estimation of incremental costs. Health Econ 1997; 6: 479-89
26. Enckevort PJ, TenVergert EM, Bonsel GJ. Technology assessment of the Dutch lung transplantation program. Int J Technol Assess Health Care 1998; 14: 344-56
27. Torrance GW, Siegel JE, Luce BR. Framing and designing the cost-effectiveness analysis. In: Gold MR, Siegel JE, Russel LB, et al., editors. Cost effectiveness in health and medicine. New York (NY): Oxford University Press, 1996
28. Drummond MF, Jefferson TO, BMJ Economic Evaluation Working Party. Guidelines for authors and peer reviewers of economic submissions to BMJ. BMJ 1996 Aug 3; 313 (7052): 275-83